CollPlant Biotechnologies (CLGN) Change in Acquisitions & Divestments (2021 - 2023)
CollPlant Biotechnologies (CLGN) posted Change in Acquisitions & Divestments of -$211000.0 for Q4 2023, up 98.94% on a QoQ basis from -$20.0 million in Q4 2022, and up 98.94% year-over-year from -$106059.5 in Q4 2022.
CollPlant Biotechnologies (CLGN) Change in Acquisitions & Divestments (2021 - 2023) Analysis & Trends
CollPlant Biotechnologies' Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at -$211000.0 for Q4 2023.
- Quarterly Change in Acquisitions & Divestments rose 98.94% year-over-year to -$211000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2024 was -$211000.0 (up 98.96% YoY) and the FY2024 annual result came in at -$57000.0, up 78.89% from the prior year.
- Change in Acquisitions & Divestments was -$211000.0 for Q4 2023 at CollPlant Biotechnologies, up from -$20.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at -$211000.0 in Q4 2023 and bottomed at -$30.0 million in Q1 2021.
- A 3-year average of -$20.1 million and a median of -$25.0 million in 2021 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments soared 33.33% — and 2023, when it jumped 98.94%.
- CollPlant Biotechnologies' Change in Acquisitions & Divestments stood at -$30.0 million in 2021, then soared by 33.33% to -$20.0 million in 2022, then soared by 98.94% to -$211000.0 in 2023.
- Business Quant data shows CLGN's Change in Acquisitions & Divestments at -$211000.0 in Q4 2023, -$20.0 million in Q4 2022, and -$30.0 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -211,000.00 |
| Dec 31, 2023 | -211,000.00 |
| Dec 31, 2022 | -20.00 Mn |
| Dec 31, 2022 | -20.00 Mn |
| Dec 31, 2021 | -30.00 Mn |
| Dec 31, 2021 | -30.00 Mn |
| Mar 31, 2021 | -30.00 Mn |
| Mar 31, 2021 | -30.00 Mn |